HSIC vs. PDCO, OMI, MCK, COR, CAH, A, ARGX, GEHC, DXCM, and ONC
Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Patterson Companies (PDCO), Owens & Minor (OMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Agilent Technologies (A), argenx (ARGX), GE HealthCare Technologies (GEHC), DexCom (DXCM), and Beigene (ONC). These companies are all part of the "medical" sector.
Henry Schein vs. Its Competitors
Patterson Companies (NASDAQ:PDCO) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.
85.4% of Patterson Companies shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 1.9% of Patterson Companies shares are owned by company insiders. Comparatively, 1.1% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Patterson Companies has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.
In the previous week, Henry Schein had 1 more articles in the media than Patterson Companies. MarketBeat recorded 2 mentions for Henry Schein and 1 mentions for Patterson Companies. Henry Schein's average media sentiment score of 1.00 beat Patterson Companies' score of 0.40 indicating that Henry Schein is being referred to more favorably in the news media.
Henry Schein has a net margin of 3.21% compared to Patterson Companies' net margin of 2.37%. Patterson Companies' return on equity of 19.77% beat Henry Schein's return on equity.
Patterson Companies presently has a consensus target price of $26.57, indicating a potential downside of 15.19%. Henry Schein has a consensus target price of $79.30, indicating a potential upside of 8.93%. Given Henry Schein's stronger consensus rating and higher possible upside, analysts clearly believe Henry Schein is more favorable than Patterson Companies.
Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
Summary
Henry Schein beats Patterson Companies on 14 of the 17 factors compared between the two stocks.
Get Henry Schein News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Henry Schein Competitors List
Related Companies and Tools
This page (NASDAQ:HSIC) was last updated on 6/25/2025 by MarketBeat.com Staff